Technical Analysis for ORINF - Orion Oyj

Grade Last Price % Change Price Change
grade C 33.95 2.26% 0.7500
ORINF closed up 2.26 percent on Thursday, August 1, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical ORINF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 2.26%
Hot IPO Pullback Bullish Swing Setup 2.26%
Narrow Range Bar Range Contraction 2.26%
New 52 Week Low Weakness 2.26%
Down 3 Days in a Row Weakness 2.26%
Gapped Down Weakness 2.26%
Hot IPO Pullback Bullish Swing Setup -8.98%
Narrow Range Bar Range Contraction -8.98%

Older signals for ORINF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. This segment also markets and sells veterinary drugs manufactured by other international companies. The Diagnostics segment develops, manufactures, and markets in vitro diagnostic test systems and tests for diagnosing diseases and monitoring treatment efficacy. Orion Oyj has a strategic alliance with Novan, Inc. to manufacture topical nitric oxide-releasing product candidates; and research collaboration with Fifth Corner Inc. to seek solutions to improve the quality of life of prostate cancer patients. The company was founded in 1917 and is headquartered in Espoo, Finland.
Health Pharmaceuticals Pharmaceutical Industry Pharmaceutical Industry In China Pharmaceuticals Policy Medication Diseases Active Pharmaceutical Ingredients Prostate Cancer Diagnostic Tests Self Care Offers Contract Manufacturing Services Markets Pharmaceuticals Orion Oyj
Is ORINF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 39.7096
52 Week Low 33.2
Average Volume 341
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.9500
Resistance 3 (R3) 33.9500 33.9500 33.9500
Resistance 2 (R2) 33.9500 33.9500 33.9500 33.9500
Resistance 1 (R1) 33.9500 33.9500 33.9500 33.9500 33.9500
Pivot Point 33.9500 33.9500 33.9500 33.9500 33.9500
Support 1 (S1) 33.9500 33.9500 33.9500 33.9500 33.9500
Support 2 (S2) 33.9500 33.9500 33.9500 33.9500
Support 3 (S3) 33.9500 33.9500 33.9500
Support 4 (S4) 33.9500